HEADER HYDROLASE 28-JUN-03 1PVS TITLE 3-METHYLADENINE GLCOSYLASE II(ALKA) HYPOXANTHINE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA-3-METHYLADENINE GLYCOSYLASE II; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3-METHYLADENINE-DNA GLYCOSYLASE II, INDUCIBLE, TAG II, DNA- COMPND 5 3-METHYLADENINE GLYCOSIDASE II; COMPND 6 EC: 3.2.2.21; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: ALKA OR AIDA OR B2068; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS ALKA, HYPOXANTHINE, DNA GLYCOSYLASE, DNA REPAIR, REACTION-PRODUCT KEYWDS 2 COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.TEALE REVDAT 3 14-FEB-24 1PVS 1 REMARK REVDAT 2 24-FEB-09 1PVS 1 VERSN REVDAT 1 08-JUN-04 1PVS 0 JRNL AUTH M.TEALE,J.SYMERSKY,L.DELUCAS JRNL TITL 3-METHYLADENINE-DNA GLYCOSYLASE II: THE CRYSTAL STRUCTURE OF JRNL TITL 2 AN ALKA-HYPOXANTHINE COMPLEX SUGGESTS THE POSSIBILITY OF JRNL TITL 3 PRODUCT INHIBITION. JRNL REF BIOCONJUG.CHEM. V. 13 403 2002 JRNL REFN ISSN 1043-1802 JRNL PMID 12009927 JRNL DOI 10.1021/BC015527V REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.3 REMARK 3 NUMBER OF REFLECTIONS : 17875 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1734 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1907 REMARK 3 BIN R VALUE (WORKING SET) : 0.2530 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 209 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.017 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4430 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 226 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.91000 REMARK 3 B22 (A**2) : 0.22000 REMARK 3 B33 (A**2) : 1.70000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.84000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 20.70 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 3 : HYPO.PARAM REMARK 3 PARAMETER FILE 4 : WATER.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 3 : HYPO.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PVS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-03. REMARK 100 THE DEPOSITION ID IS D_1000019613. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19046 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 19.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.98950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 273 CB - CG - CD1 ANGL. DEV. = 4.0 DEGREES REMARK 500 TYR B 273 CB - CG - CD1 ANGL. DEV. = 4.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 27 -53.56 -126.51 REMARK 500 HIS A 57 52.35 37.59 REMARK 500 LEU A 125 49.27 35.39 REMARK 500 PHE A 245 72.02 -119.61 REMARK 500 PRO A 262 39.06 -99.72 REMARK 500 ASP A 280 -156.26 -79.03 REMARK 500 SER B 26 -0.88 82.18 REMARK 500 ALA B 31 -164.58 -127.90 REMARK 500 HIS B 57 43.13 37.24 REMARK 500 PRO B 150 -18.90 -49.28 REMARK 500 PRO B 262 35.16 -99.66 REMARK 500 ASP B 280 -136.96 -77.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER A 26 -18.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7HP B 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7HP A 800 DBREF 1PVS A 1 282 UNP P04395 3MG2_ECOLI 1 282 DBREF 1PVS B 1 282 UNP P04395 3MG2_ECOLI 1 282 SEQRES 1 A 282 MET TYR THR LEU ASN TRP GLN PRO PRO TYR ASP TRP SER SEQRES 2 A 282 TRP MET LEU GLY PHE LEU ALA ALA ARG ALA VAL SER SER SEQRES 3 A 282 VAL GLU THR VAL ALA ASP SER TYR TYR ALA ARG SER LEU SEQRES 4 A 282 ALA VAL GLY GLU TYR ARG GLY VAL VAL THR ALA ILE PRO SEQRES 5 A 282 ASP ILE ALA ARG HIS THR LEU HIS ILE ASN LEU SER ALA SEQRES 6 A 282 GLY LEU GLU PRO VAL ALA ALA GLU CYS LEU ALA LYS MET SEQRES 7 A 282 SER ARG LEU PHE ASP LEU GLN CYS ASN PRO GLN ILE VAL SEQRES 8 A 282 ASN GLY ALA LEU GLY ARG LEU GLY ALA ALA ARG PRO GLY SEQRES 9 A 282 LEU ARG LEU PRO GLY CYS VAL ASP ALA PHE GLU GLN GLY SEQRES 10 A 282 VAL ARG ALA ILE LEU GLY GLN LEU VAL SER VAL ALA MET SEQRES 11 A 282 ALA ALA LYS LEU THR ALA ARG VAL ALA GLN LEU TYR GLY SEQRES 12 A 282 GLU ARG LEU ASP ASP PHE PRO GLU TYR ILE CYS PHE PRO SEQRES 13 A 282 THR PRO GLN ARG LEU ALA ALA ALA ASP PRO GLN ALA LEU SEQRES 14 A 282 LYS ALA LEU GLY MET PRO LEU LYS ARG ALA GLU ALA LEU SEQRES 15 A 282 ILE HIS LEU ALA ASN ALA ALA LEU GLU GLY THR LEU PRO SEQRES 16 A 282 MET THR ILE PRO GLY ASP VAL GLU GLN ALA MET LYS THR SEQRES 17 A 282 LEU GLN THR PHE PRO GLY ILE GLY ARG TRP THR ALA ASN SEQRES 18 A 282 TYR PHE ALA LEU ARG GLY TRP GLN ALA LYS ASP VAL PHE SEQRES 19 A 282 LEU PRO ASP ASP TYR LEU ILE LYS GLN ARG PHE PRO GLY SEQRES 20 A 282 MET THR PRO ALA GLN ILE ARG ARG TYR ALA GLU ARG TRP SEQRES 21 A 282 LYS PRO TRP ARG SER TYR ALA LEU LEU HIS ILE TRP TYR SEQRES 22 A 282 THR GLU GLY TRP GLN PRO ASP GLU ALA SEQRES 1 B 282 MET TYR THR LEU ASN TRP GLN PRO PRO TYR ASP TRP SER SEQRES 2 B 282 TRP MET LEU GLY PHE LEU ALA ALA ARG ALA VAL SER SER SEQRES 3 B 282 VAL GLU THR VAL ALA ASP SER TYR TYR ALA ARG SER LEU SEQRES 4 B 282 ALA VAL GLY GLU TYR ARG GLY VAL VAL THR ALA ILE PRO SEQRES 5 B 282 ASP ILE ALA ARG HIS THR LEU HIS ILE ASN LEU SER ALA SEQRES 6 B 282 GLY LEU GLU PRO VAL ALA ALA GLU CYS LEU ALA LYS MET SEQRES 7 B 282 SER ARG LEU PHE ASP LEU GLN CYS ASN PRO GLN ILE VAL SEQRES 8 B 282 ASN GLY ALA LEU GLY ARG LEU GLY ALA ALA ARG PRO GLY SEQRES 9 B 282 LEU ARG LEU PRO GLY CYS VAL ASP ALA PHE GLU GLN GLY SEQRES 10 B 282 VAL ARG ALA ILE LEU GLY GLN LEU VAL SER VAL ALA MET SEQRES 11 B 282 ALA ALA LYS LEU THR ALA ARG VAL ALA GLN LEU TYR GLY SEQRES 12 B 282 GLU ARG LEU ASP ASP PHE PRO GLU TYR ILE CYS PHE PRO SEQRES 13 B 282 THR PRO GLN ARG LEU ALA ALA ALA ASP PRO GLN ALA LEU SEQRES 14 B 282 LYS ALA LEU GLY MET PRO LEU LYS ARG ALA GLU ALA LEU SEQRES 15 B 282 ILE HIS LEU ALA ASN ALA ALA LEU GLU GLY THR LEU PRO SEQRES 16 B 282 MET THR ILE PRO GLY ASP VAL GLU GLN ALA MET LYS THR SEQRES 17 B 282 LEU GLN THR PHE PRO GLY ILE GLY ARG TRP THR ALA ASN SEQRES 18 B 282 TYR PHE ALA LEU ARG GLY TRP GLN ALA LYS ASP VAL PHE SEQRES 19 B 282 LEU PRO ASP ASP TYR LEU ILE LYS GLN ARG PHE PRO GLY SEQRES 20 B 282 MET THR PRO ALA GLN ILE ARG ARG TYR ALA GLU ARG TRP SEQRES 21 B 282 LYS PRO TRP ARG SER TYR ALA LEU LEU HIS ILE TRP TYR SEQRES 22 B 282 THR GLU GLY TRP GLN PRO ASP GLU ALA HET 7HP A 800 10 HET 7HP B 700 10 HETNAM 7HP 7-HYDROXY-PYRAZOLO[4,3-D]PYRIMIDINE FORMUL 3 7HP 2(C5 H4 N4 O) FORMUL 5 HOH *226(H2 O) HELIX 1 1 ASP A 11 ALA A 23 1 13 HELIX 2 2 ALA A 65 PRO A 69 5 5 HELIX 3 3 VAL A 70 ASP A 83 1 14 HELIX 4 4 ASN A 87 GLY A 96 1 10 HELIX 5 5 GLY A 96 ALA A 101 1 6 HELIX 6 6 ASP A 112 GLY A 123 1 12 HELIX 7 7 SER A 127 GLY A 143 1 17 HELIX 8 8 THR A 157 ALA A 163 1 7 HELIX 9 9 ASP A 165 LEU A 172 1 8 HELIX 10 10 PRO A 175 GLY A 192 1 18 HELIX 11 11 ASP A 201 GLN A 210 1 10 HELIX 12 12 GLY A 216 TRP A 228 1 13 HELIX 13 13 ASP A 238 PHE A 245 1 8 HELIX 14 14 THR A 249 GLU A 258 1 10 HELIX 15 15 ARG A 259 LYS A 261 5 3 HELIX 16 16 TRP A 263 THR A 274 1 12 HELIX 17 17 ASP B 11 ALA B 23 1 13 HELIX 18 18 ILE B 54 ARG B 56 5 3 HELIX 19 19 ALA B 65 PRO B 69 5 5 HELIX 20 20 VAL B 70 ASP B 83 1 14 HELIX 21 21 ASN B 87 GLY B 96 1 10 HELIX 22 22 GLY B 96 ALA B 101 1 6 HELIX 23 23 ASP B 112 GLY B 123 1 12 HELIX 24 24 SER B 127 GLY B 143 1 17 HELIX 25 25 THR B 157 ALA B 163 1 7 HELIX 26 26 ASP B 165 LEU B 172 1 8 HELIX 27 27 PRO B 175 GLU B 191 1 17 HELIX 28 28 ASP B 201 THR B 211 1 11 HELIX 29 29 GLY B 216 TRP B 228 1 13 HELIX 30 30 ASP B 238 PHE B 245 1 8 HELIX 31 31 THR B 249 GLU B 258 1 10 HELIX 32 32 ARG B 259 LYS B 261 5 3 HELIX 33 33 TRP B 263 TYR B 273 1 11 SHEET 1 A 5 TYR A 2 ASN A 5 0 SHEET 2 A 5 THR A 58 LEU A 63 -1 O ILE A 61 N TYR A 2 SHEET 3 A 5 TYR A 44 ASP A 53 -1 N ILE A 51 O HIS A 60 SHEET 4 A 5 TYR A 35 VAL A 41 -1 N TYR A 35 O ALA A 50 SHEET 5 A 5 GLU A 28 VAL A 30 -1 N THR A 29 O ALA A 36 SHEET 1 B 2 GLU A 144 ARG A 145 0 SHEET 2 B 2 ILE A 153 CYS A 154 -1 O CYS A 154 N GLU A 144 SHEET 1 C 5 TYR B 2 ASN B 5 0 SHEET 2 C 5 THR B 58 LEU B 63 -1 O LEU B 59 N LEU B 4 SHEET 3 C 5 TYR B 44 ASP B 53 -1 N ILE B 51 O HIS B 60 SHEET 4 C 5 TYR B 35 VAL B 41 -1 N TYR B 35 O ALA B 50 SHEET 5 C 5 GLU B 28 VAL B 30 -1 N THR B 29 O ALA B 36 CISPEP 1 PRO A 8 PRO A 9 0 -0.35 CISPEP 2 LYS A 261 PRO A 262 0 -0.28 CISPEP 3 PRO B 8 PRO B 9 0 0.08 CISPEP 4 LYS B 261 PRO B 262 0 0.36 SITE 1 AC1 8 GLY B 123 GLN B 124 LEU B 125 VAL B 126 SITE 2 AC1 8 TRP B 218 ASP B 237 ASP B 238 TYR B 239 SITE 1 AC2 10 GLY A 123 GLN A 124 LEU A 125 VAL A 126 SITE 2 AC2 10 TRP A 218 ASP A 237 ASP A 238 TYR A 239 SITE 3 AC2 10 HOH A 811 HOH A 876 CRYST1 58.005 75.979 61.417 90.00 110.03 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017240 0.000000 0.006285 0.00000 SCALE2 0.000000 0.013162 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017331 0.00000